Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Kitos

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Biochemical Pharmacology|August 15, 1981
Teratogenic effects of cholinergic insecticides in chick embryos--II. Effects on the NAD content of early embryosP A Kitos, D S Anderson, E M Uyeki, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 19, 1998
Antibody transport in cultured tumor cell layersE M Topp, P A Kitos, V Vijaykumar, et al.
Bioorganic & Medicinal Chemistry|July 1, 1993
Evaluation of functional analogs of CC-1065 and the duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-on e (C2BI) alkylation subunitD L Boger, D S Johnson, M S Palanki, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Functionalized analogues of 5,8,10-trideazafolate: development of an enzyme-assembled tight binding inhibitor of GAR Tfase and a potential irreversible inhibitor of AICAR TfaseD L Boger, N E Haynes, M S Warren, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Multisubstrate analogue based on 5,8,10-trideazafolateD L Boger, N E Haynes, M S Warren, et al.
Journal of Medicinal Chemistry|October 1, 1987
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-dionesD L Boger, M Yasuda, L A Mitscher, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
10-Formyl-5,8,10-trideazafolic acid (10-formyl-TDAF): a potent inhibitor of glycinamide ribonucleotide transformylaseD L Boger, N E Haynes, P A Kitos, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Functionalized analogues of 5,8,10-trideazafolate as potential inhibitors of GAR Tfase or AICAR TfaseD L Boger, N E Haynes, M S Warren, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Abenzyl 10-formyl-trideazafolic acid (abenzyl 10-formyl-TDAF): an effective inhibitor of glycinamide ribonucleotide transformylaseD L Boger, N E Haynes, M S Warren, et al.
Chemico-Biological Interactions|January 1, 1990
A demonstration of the intrinsic importance of stabilizing hydrophobic binding and non-covalent van der Waals contacts dominant in the non-covalent CC-1065/B-DNA bindingD L Boger, B J Invergo, R S Coleman, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Biochemical Pharmacology|August 15, 1981
Teratogenic effects of cholinergic insecticides in chick embryos--II. Effects on the NAD content of early embryosP A Kitos, D S Anderson, E M Uyeki, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 19, 1998
Antibody transport in cultured tumor cell layersE M Topp, P A Kitos, V Vijaykumar, et al.
Bioorganic & Medicinal Chemistry|July 1, 1993
Evaluation of functional analogs of CC-1065 and the duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-on e (C2BI) alkylation subunitD L Boger, D S Johnson, M S Palanki, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Functionalized analogues of 5,8,10-trideazafolate: development of an enzyme-assembled tight binding inhibitor of GAR Tfase and a potential irreversible inhibitor of AICAR TfaseD L Boger, N E Haynes, M S Warren, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Multisubstrate analogue based on 5,8,10-trideazafolateD L Boger, N E Haynes, M S Warren, et al.
Journal of Medicinal Chemistry|October 1, 1987
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-dionesD L Boger, M Yasuda, L A Mitscher, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
10-Formyl-5,8,10-trideazafolic acid (10-formyl-TDAF): a potent inhibitor of glycinamide ribonucleotide transformylaseD L Boger, N E Haynes, P A Kitos, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Functionalized analogues of 5,8,10-trideazafolate as potential inhibitors of GAR Tfase or AICAR TfaseD L Boger, N E Haynes, M S Warren, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Abenzyl 10-formyl-trideazafolic acid (abenzyl 10-formyl-TDAF): an effective inhibitor of glycinamide ribonucleotide transformylaseD L Boger, N E Haynes, M S Warren, et al.
Chemico-Biological Interactions|January 1, 1990
A demonstration of the intrinsic importance of stabilizing hydrophobic binding and non-covalent van der Waals contacts dominant in the non-covalent CC-1065/B-DNA bindingD L Boger, B J Invergo, R S Coleman, et al.
Pageof 5